Wolverine Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-45,133
Closed -$77K 5640
2022
Q2
$77K Buy
+45,133
New +$66.6K ﹤0.01% 3927
2021
Q4
Sell
-28,367
Closed -$105K 7243
2021
Q3
$128K Buy
28,367
+6,528
+30% +$31.4K ﹤0.01% 5644
2021
Q2
$128K Buy
21,839
+7,679
+54% +$45K ﹤0.01% 5281
2021
Q1
$96K Sell
14,160
-7,805
-36% -$52.3K ﹤0.01% 5450
2020
Q4
$108K Sell
21,965
-1,297
-6% -$6.56K ﹤0.01% 4448
2020
Q3
$138K Buy
+23,262
New +$139K ﹤0.01% 4012
2019
Q4
Sell
-17,702
Closed -$71K 5405
2019
Q3
$71K Buy
17,702
+3,977
+29% +$32.2K ﹤0.01% 3960
2019
Q2
$204K Buy
13,725
+5,230
+62% +$94.5K ﹤0.01% 3703
2019
Q1
$211K Sell
8,495
-25,495
-75% -$639K ﹤0.01% 3768
2018
Q4
$611K Buy
+33,990
New +$695K ﹤0.01% 2451
2018
Q3
Sell
-11,608
Closed -$449K 6167
2018
Q2
$613K Hold
11,608
﹤0.01% 2816
2018
Q1
$613K Sell
11,608
-31,340
-73% -$1.83M ﹤0.01% 2816
2017
Q4
$2.92M Sell
42,948
-30,292
-41% -$2.12M 0.01% 1237
2017
Q3
$6.04M Buy
73,240
+932
+1% +$73.9K 0.02% 662
2017
Q2
$6.65M Buy
72,308
+38,197
+112% +$2.34M 0.03% 537
2017
Q1
$2.14M Buy
+34,111
New +$2.07M 0.01% 1142
2016
Q3
Sell
-15,957
Closed -$342K 5257
2016
Q2
$240K Buy
+15,957
New +$233K ﹤0.01% 3060

Other funds holding CLVS